Tightly targeted cancer therapy receives marketing approval.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
DeCarvalho, S., Rand, H. J. & Lewis, A. Nature 202, 255-258 (1964).
Junutula, J. R. et al. Nature Biotechnol. 26, 925-932 (2008).
Related links
Related links
Related links in Nature Research
Translational Cancer Research special
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. Toxic antibodies blitz tumours. Nature (2011). https://doi.org/10.1038/476380a
Published:
DOI: https://doi.org/10.1038/476380a